Antifungal Drugs Market Share, Size, Industry Updates, Top Players, Demand, Analysis and Forecast 2022-2027


According to IMARC Group’s latest report entitled ” Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027‘ provides a comprehensive analysis of the industry providing insights into the Global antifungal market share. The report also includes competitive and regional analysis along with current advances in the global market.

A Closer Look at the Global Antifungal Drugs Market Size | 2022

The global antifungal drug market size reached US$14.0 billion in 2021. Looking ahead, IMARC Group expects the market to reach $17.4 billion by 2027, at a growth rate (CAGR) of 3.7% over 2022-2027.

Antifungal or antifungal drugs are used to stop the growth of infection-causing fungi. Such microorganisms can cause tinea, fungal infections, and nail and skin inflammation, which can be treated and treated by administering oral or injectable antifungal drugs. Fungal infections can also lead to diseases of the circulatory and respiratory tract when inhaled. Antifungal drugs can be divided into three classes based on their site of action, including polyenes, azoles, and allylamines. They are used extensively to treat various conditions such as athlete’s foot, candidiasis, ringworm, fungal meningitis and aspergillosis. Currently, antifungal drugs are primarily available in cream, spray, tablet, over-the-counter (OTC), and intravenous (IV) injection forms.

Find out what’s new in the antifungal market:

The increasing prevalence of fungal and nosocomial infections around the world creates a positive outlook for the market. Accordingly, the growing demand for effective OTC drugs such as antifungals across the healthcare sector to treat systemic and superficial infections of the skin, eyes, vagina and mouth is driving the market growth. Additionally, the increasing number of drug approvals and widespread adoption of nanotechnology to formulate advanced antifungal drugs that improve patient outcomes support market growth. This is further influenced by the advent of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections that act as a growth-inducing factor. In addition, continuous research and development (R&D) activities in the field of medical sciences to develop novel antifungal drugs in different modes of administration and their availability through multiple distribution channels support the market growth.

Get the FREE PDF sample report:

Antifungal Drugs Market 2022-2027 Competitive Analysis and Segmentation:

Competitive landscape with key players:

The competitive landscape of the global Antifungal Drugs Market has been studied in the report that contains the detailed profiles of the major market players.

Antifungal Drugs Market Research Report

Key Players Covered in Global Antifungal Drugs Market Research Report: Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi SA and Scynexis Inc.

Antifungal Drugs Market Segmentation:

The report has segmented the global antifungal drugs market by drug class, indication and region.

Based on drug class:

  • azoles
  • Echinocandins
  • polyenes
  • allylamines
  • Other

Based on indication:

  • dermatophytosis
  • aspergillosis
  • candidiasis
  • Other

Regional Analysis:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, others)
  • Europe: (Germany, France, UK, Italy, Spain, Russia, others)
  • Latin America: (Brazil, Mexico, others)
  • Middle East and Africa

Purchase Report:

This report can serve as an excellent guide for investors, researchers, consultants, marketers, and anyone planning to enter the market in any way.

Key highlights of the report:

  • Market performance (2016-2021)
  • Market Outlook (2022-2027)
  • industry trends
  • Market drivers and success factors
  • The impact of COVID-19 on the global market
  • Analysis of the value chain
  • Structure of the global market
  • Comprehensive mapping of the competitive landscape

If you require specific information that is not currently in the scope of the report, we will provide it as part of the customization.

You might also read: Market share of safety pins

about us

IMARC Group is a leading market research company providing management strategies and market research worldwide. We partner with clients across sectors and geographies to identify their most valuable opportunities, address their most critical challenges, and transform their businesses.

Our offer includes comprehensive market information in the form of research reports, production cost reports, feasibility studies and consulting services. Our team, which includes experienced researchers and analysts across multiple industries, is dedicated to delivering high-quality data and insights to our clientele, ranging from small and medium-sized businesses to Fortune 1000 companies.

IMARC’s information products cover key market, scientific, economic and technological developments for executives in pharmaceutical, industrial and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food & beverage, travel & tourism, nanotechnology and advanced processing methods are at the forefront of the company’s expertise.

Contact us:

30 N Gould Street, Ste R
Sheridan, WY82801, USA
E-mail: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800


Comments are closed.